Global B Streptococcus (GBS) Infection Treatment Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global B Streptococcus (GBS) Infection Treatment market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global B Streptococcus (GBS) Infection Treatment market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global B Streptococcus (GBS) Infection Treatment market size and forecasts, in consumption value ($ Million), 2018-2029
Global B Streptococcus (GBS) Infection Treatment market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global B Streptococcus (GBS) Infection Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global B Streptococcus (GBS) Infection Treatment market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for B Streptococcus (GBS) Infection Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global B Streptococcus (GBS) Infection Treatment market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer Inc., Alopexx Pharmaceuticals, LLC, Wellstat Vaccines LLC, Minervax ApS and Novartis and etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
B Streptococcus (GBS) Infection Treatment market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe B Streptococcus (GBS) Infection Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of B Streptococcus (GBS) Infection Treatment, with revenue, gross margin and global market share of B Streptococcus (GBS) Infection Treatment from 2018 to 2023.
Chapter 3, the B Streptococcus (GBS) Infection Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and B Streptococcus (GBS) Infection Treatment market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of B Streptococcus (GBS) Infection Treatment.
Chapter 13, to describe B Streptococcus (GBS) Infection Treatment research findings and conclusion.
This report is a detailed and comprehensive analysis for global B Streptococcus (GBS) Infection Treatment market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global B Streptococcus (GBS) Infection Treatment market size and forecasts, in consumption value ($ Million), 2018-2029
Global B Streptococcus (GBS) Infection Treatment market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global B Streptococcus (GBS) Infection Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global B Streptococcus (GBS) Infection Treatment market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for B Streptococcus (GBS) Infection Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global B Streptococcus (GBS) Infection Treatment market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer Inc., Alopexx Pharmaceuticals, LLC, Wellstat Vaccines LLC, Minervax ApS and Novartis and etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
B Streptococcus (GBS) Infection Treatment market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Prenatal-onset GBS Disease
- Early-onset GBS Disease
- Late-onset GBS Disease
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Pfizer Inc.
- Alopexx Pharmaceuticals, LLC
- Wellstat Vaccines LLC
- Minervax ApS
- Novartis
- GlaxoSmithKline
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe B Streptococcus (GBS) Infection Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of B Streptococcus (GBS) Infection Treatment, with revenue, gross margin and global market share of B Streptococcus (GBS) Infection Treatment from 2018 to 2023.
Chapter 3, the B Streptococcus (GBS) Infection Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and B Streptococcus (GBS) Infection Treatment market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of B Streptococcus (GBS) Infection Treatment.
Chapter 13, to describe B Streptococcus (GBS) Infection Treatment research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of B Streptococcus (GBS) Infection Treatment
1.2 Market Estimation Caveats and Base Year
1.3 Classification of B Streptococcus (GBS) Infection Treatment by Type
1.3.1 Overview: Global B Streptococcus (GBS) Infection Treatment Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global B Streptococcus (GBS) Infection Treatment Consumption Value Market Share by Type in 2022
1.3.3 Prenatal-onset GBS Disease
1.3.4 Early-onset GBS Disease
1.3.5 Late-onset GBS Disease
1.4 Global B Streptococcus (GBS) Infection Treatment Market by Application
1.4.1 Overview: Global B Streptococcus (GBS) Infection Treatment Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals Pharmacies
1.4.3 Retail Pharmacies
1.4.4 Online Pharmacies
1.5 Global B Streptococcus (GBS) Infection Treatment Market Size & Forecast
1.6 Global B Streptococcus (GBS) Infection Treatment Market Size and Forecast by Region
1.6.1 Global B Streptococcus (GBS) Infection Treatment Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global B Streptococcus (GBS) Infection Treatment Market Size by Region, (2018-2029)
1.6.3 North America B Streptococcus (GBS) Infection Treatment Market Size and Prospect (2018-2029)
1.6.4 Europe B Streptococcus (GBS) Infection Treatment Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific B Streptococcus (GBS) Infection Treatment Market Size and Prospect (2018-2029)
1.6.6 South America B Streptococcus (GBS) Infection Treatment Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa B Streptococcus (GBS) Infection Treatment Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Pfizer Inc.
2.1.1 Pfizer Inc. Details
2.1.2 Pfizer Inc. Major Business
2.1.3 Pfizer Inc. B Streptococcus (GBS) Infection Treatment Product and Solutions
2.1.4 Pfizer Inc. B Streptococcus (GBS) Infection Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Pfizer Inc. Recent Developments and Future Plans
2.2 Alopexx Pharmaceuticals, LLC
2.2.1 Alopexx Pharmaceuticals, LLC Details
2.2.2 Alopexx Pharmaceuticals, LLC Major Business
2.2.3 Alopexx Pharmaceuticals, LLC B Streptococcus (GBS) Infection Treatment Product and Solutions
2.2.4 Alopexx Pharmaceuticals, LLC B Streptococcus (GBS) Infection Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Alopexx Pharmaceuticals, LLC Recent Developments and Future Plans
2.3 Wellstat Vaccines LLC
2.3.1 Wellstat Vaccines LLC Details
2.3.2 Wellstat Vaccines LLC Major Business
2.3.3 Wellstat Vaccines LLC B Streptococcus (GBS) Infection Treatment Product and Solutions
2.3.4 Wellstat Vaccines LLC B Streptococcus (GBS) Infection Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Wellstat Vaccines LLC Recent Developments and Future Plans
2.4 Minervax ApS
2.4.1 Minervax ApS Details
2.4.2 Minervax ApS Major Business
2.4.3 Minervax ApS B Streptococcus (GBS) Infection Treatment Product and Solutions
2.4.4 Minervax ApS B Streptococcus (GBS) Infection Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Minervax ApS Recent Developments and Future Plans
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business
2.5.3 Novartis B Streptococcus (GBS) Infection Treatment Product and Solutions
2.5.4 Novartis B Streptococcus (GBS) Infection Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Novartis Recent Developments and Future Plans
2.6 GlaxoSmithKline
2.6.1 GlaxoSmithKline Details
2.6.2 GlaxoSmithKline Major Business
2.6.3 GlaxoSmithKline B Streptococcus (GBS) Infection Treatment Product and Solutions
2.6.4 GlaxoSmithKline B Streptococcus (GBS) Infection Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 GlaxoSmithKline Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global B Streptococcus (GBS) Infection Treatment Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of B Streptococcus (GBS) Infection Treatment by Company Revenue
3.2.2 Top 3 B Streptococcus (GBS) Infection Treatment Players Market Share in 2022
3.2.3 Top 6 B Streptococcus (GBS) Infection Treatment Players Market Share in 2022
3.3 B Streptococcus (GBS) Infection Treatment Market: Overall Company Footprint Analysis
3.3.1 B Streptococcus (GBS) Infection Treatment Market: Region Footprint
3.3.2 B Streptococcus (GBS) Infection Treatment Market: Company Product Type Footprint
3.3.3 B Streptococcus (GBS) Infection Treatment Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global B Streptococcus (GBS) Infection Treatment Consumption Value and Market Share by Type (2018-2023)
4.2 Global B Streptococcus (GBS) Infection Treatment Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global B Streptococcus (GBS) Infection Treatment Consumption Value Market Share by Application (2018-2023)
5.2 Global B Streptococcus (GBS) Infection Treatment Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America B Streptococcus (GBS) Infection Treatment Consumption Value by Type (2018-2029)
6.2 North America B Streptococcus (GBS) Infection Treatment Consumption Value by Application (2018-2029)
6.3 North America B Streptococcus (GBS) Infection Treatment Market Size by Country
6.3.1 North America B Streptococcus (GBS) Infection Treatment Consumption Value by Country (2018-2029)
6.3.2 United States B Streptococcus (GBS) Infection Treatment Market Size and Forecast (2018-2029)
6.3.3 Canada B Streptococcus (GBS) Infection Treatment Market Size and Forecast (2018-2029)
6.3.4 Mexico B Streptococcus (GBS) Infection Treatment Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe B Streptococcus (GBS) Infection Treatment Consumption Value by Type (2018-2029)
7.2 Europe B Streptococcus (GBS) Infection Treatment Consumption Value by Application (2018-2029)
7.3 Europe B Streptococcus (GBS) Infection Treatment Market Size by Country
7.3.1 Europe B Streptococcus (GBS) Infection Treatment Consumption Value by Country (2018-2029)
7.3.2 Germany B Streptococcus (GBS) Infection Treatment Market Size and Forecast (2018-2029)
7.3.3 France B Streptococcus (GBS) Infection Treatment Market Size and Forecast (2018-2029)
7.3.4 United Kingdom B Streptococcus (GBS) Infection Treatment Market Size and Forecast (2018-2029)
7.3.5 Russia B Streptococcus (GBS) Infection Treatment Market Size and Forecast (2018-2029)
7.3.6 Italy B Streptococcus (GBS) Infection Treatment Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific B Streptococcus (GBS) Infection Treatment Consumption Value by Type (2018-2029)
8.2 Asia-Pacific B Streptococcus (GBS) Infection Treatment Consumption Value by Application (2018-2029)
8.3 Asia-Pacific B Streptococcus (GBS) Infection Treatment Market Size by Region
8.3.1 Asia-Pacific B Streptococcus (GBS) Infection Treatment Consumption Value by Region (2018-2029)
8.3.2 China B Streptococcus (GBS) Infection Treatment Market Size and Forecast (2018-2029)
8.3.3 Japan B Streptococcus (GBS) Infection Treatment Market Size and Forecast (2018-2029)
8.3.4 South Korea B Streptococcus (GBS) Infection Treatment Market Size and Forecast (2018-2029)
8.3.5 India B Streptococcus (GBS) Infection Treatment Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia B Streptococcus (GBS) Infection Treatment Market Size and Forecast (2018-2029)
8.3.7 Australia B Streptococcus (GBS) Infection Treatment Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America B Streptococcus (GBS) Infection Treatment Consumption Value by Type (2018-2029)
9.2 South America B Streptococcus (GBS) Infection Treatment Consumption Value by Application (2018-2029)
9.3 South America B Streptococcus (GBS) Infection Treatment Market Size by Country
9.3.1 South America B Streptococcus (GBS) Infection Treatment Consumption Value by Country (2018-2029)
9.3.2 Brazil B Streptococcus (GBS) Infection Treatment Market Size and Forecast (2018-2029)
9.3.3 Argentina B Streptococcus (GBS) Infection Treatment Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa B Streptococcus (GBS) Infection Treatment Consumption Value by Type (2018-2029)
10.2 Middle East & Africa B Streptococcus (GBS) Infection Treatment Consumption Value by Application (2018-2029)
10.3 Middle East & Africa B Streptococcus (GBS) Infection Treatment Market Size by Country
10.3.1 Middle East & Africa B Streptococcus (GBS) Infection Treatment Consumption Value by Country (2018-2029)
10.3.2 Turkey B Streptococcus (GBS) Infection Treatment Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia B Streptococcus (GBS) Infection Treatment Market Size and Forecast (2018-2029)
10.3.4 UAE B Streptococcus (GBS) Infection Treatment Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 B Streptococcus (GBS) Infection Treatment Market Drivers
11.2 B Streptococcus (GBS) Infection Treatment Market Restraints
11.3 B Streptococcus (GBS) Infection Treatment Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 B Streptococcus (GBS) Infection Treatment Industry Chain
12.2 B Streptococcus (GBS) Infection Treatment Upstream Analysis
12.3 B Streptococcus (GBS) Infection Treatment Midstream Analysis
12.4 B Streptococcus (GBS) Infection Treatment Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of B Streptococcus (GBS) Infection Treatment
1.2 Market Estimation Caveats and Base Year
1.3 Classification of B Streptococcus (GBS) Infection Treatment by Type
1.3.1 Overview: Global B Streptococcus (GBS) Infection Treatment Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global B Streptococcus (GBS) Infection Treatment Consumption Value Market Share by Type in 2022
1.3.3 Prenatal-onset GBS Disease
1.3.4 Early-onset GBS Disease
1.3.5 Late-onset GBS Disease
1.4 Global B Streptococcus (GBS) Infection Treatment Market by Application
1.4.1 Overview: Global B Streptococcus (GBS) Infection Treatment Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals Pharmacies
1.4.3 Retail Pharmacies
1.4.4 Online Pharmacies
1.5 Global B Streptococcus (GBS) Infection Treatment Market Size & Forecast
1.6 Global B Streptococcus (GBS) Infection Treatment Market Size and Forecast by Region
1.6.1 Global B Streptococcus (GBS) Infection Treatment Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global B Streptococcus (GBS) Infection Treatment Market Size by Region, (2018-2029)
1.6.3 North America B Streptococcus (GBS) Infection Treatment Market Size and Prospect (2018-2029)
1.6.4 Europe B Streptococcus (GBS) Infection Treatment Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific B Streptococcus (GBS) Infection Treatment Market Size and Prospect (2018-2029)
1.6.6 South America B Streptococcus (GBS) Infection Treatment Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa B Streptococcus (GBS) Infection Treatment Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Pfizer Inc.
2.1.1 Pfizer Inc. Details
2.1.2 Pfizer Inc. Major Business
2.1.3 Pfizer Inc. B Streptococcus (GBS) Infection Treatment Product and Solutions
2.1.4 Pfizer Inc. B Streptococcus (GBS) Infection Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Pfizer Inc. Recent Developments and Future Plans
2.2 Alopexx Pharmaceuticals, LLC
2.2.1 Alopexx Pharmaceuticals, LLC Details
2.2.2 Alopexx Pharmaceuticals, LLC Major Business
2.2.3 Alopexx Pharmaceuticals, LLC B Streptococcus (GBS) Infection Treatment Product and Solutions
2.2.4 Alopexx Pharmaceuticals, LLC B Streptococcus (GBS) Infection Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Alopexx Pharmaceuticals, LLC Recent Developments and Future Plans
2.3 Wellstat Vaccines LLC
2.3.1 Wellstat Vaccines LLC Details
2.3.2 Wellstat Vaccines LLC Major Business
2.3.3 Wellstat Vaccines LLC B Streptococcus (GBS) Infection Treatment Product and Solutions
2.3.4 Wellstat Vaccines LLC B Streptococcus (GBS) Infection Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Wellstat Vaccines LLC Recent Developments and Future Plans
2.4 Minervax ApS
2.4.1 Minervax ApS Details
2.4.2 Minervax ApS Major Business
2.4.3 Minervax ApS B Streptococcus (GBS) Infection Treatment Product and Solutions
2.4.4 Minervax ApS B Streptococcus (GBS) Infection Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Minervax ApS Recent Developments and Future Plans
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business
2.5.3 Novartis B Streptococcus (GBS) Infection Treatment Product and Solutions
2.5.4 Novartis B Streptococcus (GBS) Infection Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Novartis Recent Developments and Future Plans
2.6 GlaxoSmithKline
2.6.1 GlaxoSmithKline Details
2.6.2 GlaxoSmithKline Major Business
2.6.3 GlaxoSmithKline B Streptococcus (GBS) Infection Treatment Product and Solutions
2.6.4 GlaxoSmithKline B Streptococcus (GBS) Infection Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 GlaxoSmithKline Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global B Streptococcus (GBS) Infection Treatment Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of B Streptococcus (GBS) Infection Treatment by Company Revenue
3.2.2 Top 3 B Streptococcus (GBS) Infection Treatment Players Market Share in 2022
3.2.3 Top 6 B Streptococcus (GBS) Infection Treatment Players Market Share in 2022
3.3 B Streptococcus (GBS) Infection Treatment Market: Overall Company Footprint Analysis
3.3.1 B Streptococcus (GBS) Infection Treatment Market: Region Footprint
3.3.2 B Streptococcus (GBS) Infection Treatment Market: Company Product Type Footprint
3.3.3 B Streptococcus (GBS) Infection Treatment Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global B Streptococcus (GBS) Infection Treatment Consumption Value and Market Share by Type (2018-2023)
4.2 Global B Streptococcus (GBS) Infection Treatment Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global B Streptococcus (GBS) Infection Treatment Consumption Value Market Share by Application (2018-2023)
5.2 Global B Streptococcus (GBS) Infection Treatment Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America B Streptococcus (GBS) Infection Treatment Consumption Value by Type (2018-2029)
6.2 North America B Streptococcus (GBS) Infection Treatment Consumption Value by Application (2018-2029)
6.3 North America B Streptococcus (GBS) Infection Treatment Market Size by Country
6.3.1 North America B Streptococcus (GBS) Infection Treatment Consumption Value by Country (2018-2029)
6.3.2 United States B Streptococcus (GBS) Infection Treatment Market Size and Forecast (2018-2029)
6.3.3 Canada B Streptococcus (GBS) Infection Treatment Market Size and Forecast (2018-2029)
6.3.4 Mexico B Streptococcus (GBS) Infection Treatment Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe B Streptococcus (GBS) Infection Treatment Consumption Value by Type (2018-2029)
7.2 Europe B Streptococcus (GBS) Infection Treatment Consumption Value by Application (2018-2029)
7.3 Europe B Streptococcus (GBS) Infection Treatment Market Size by Country
7.3.1 Europe B Streptococcus (GBS) Infection Treatment Consumption Value by Country (2018-2029)
7.3.2 Germany B Streptococcus (GBS) Infection Treatment Market Size and Forecast (2018-2029)
7.3.3 France B Streptococcus (GBS) Infection Treatment Market Size and Forecast (2018-2029)
7.3.4 United Kingdom B Streptococcus (GBS) Infection Treatment Market Size and Forecast (2018-2029)
7.3.5 Russia B Streptococcus (GBS) Infection Treatment Market Size and Forecast (2018-2029)
7.3.6 Italy B Streptococcus (GBS) Infection Treatment Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific B Streptococcus (GBS) Infection Treatment Consumption Value by Type (2018-2029)
8.2 Asia-Pacific B Streptococcus (GBS) Infection Treatment Consumption Value by Application (2018-2029)
8.3 Asia-Pacific B Streptococcus (GBS) Infection Treatment Market Size by Region
8.3.1 Asia-Pacific B Streptococcus (GBS) Infection Treatment Consumption Value by Region (2018-2029)
8.3.2 China B Streptococcus (GBS) Infection Treatment Market Size and Forecast (2018-2029)
8.3.3 Japan B Streptococcus (GBS) Infection Treatment Market Size and Forecast (2018-2029)
8.3.4 South Korea B Streptococcus (GBS) Infection Treatment Market Size and Forecast (2018-2029)
8.3.5 India B Streptococcus (GBS) Infection Treatment Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia B Streptococcus (GBS) Infection Treatment Market Size and Forecast (2018-2029)
8.3.7 Australia B Streptococcus (GBS) Infection Treatment Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America B Streptococcus (GBS) Infection Treatment Consumption Value by Type (2018-2029)
9.2 South America B Streptococcus (GBS) Infection Treatment Consumption Value by Application (2018-2029)
9.3 South America B Streptococcus (GBS) Infection Treatment Market Size by Country
9.3.1 South America B Streptococcus (GBS) Infection Treatment Consumption Value by Country (2018-2029)
9.3.2 Brazil B Streptococcus (GBS) Infection Treatment Market Size and Forecast (2018-2029)
9.3.3 Argentina B Streptococcus (GBS) Infection Treatment Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa B Streptococcus (GBS) Infection Treatment Consumption Value by Type (2018-2029)
10.2 Middle East & Africa B Streptococcus (GBS) Infection Treatment Consumption Value by Application (2018-2029)
10.3 Middle East & Africa B Streptococcus (GBS) Infection Treatment Market Size by Country
10.3.1 Middle East & Africa B Streptococcus (GBS) Infection Treatment Consumption Value by Country (2018-2029)
10.3.2 Turkey B Streptococcus (GBS) Infection Treatment Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia B Streptococcus (GBS) Infection Treatment Market Size and Forecast (2018-2029)
10.3.4 UAE B Streptococcus (GBS) Infection Treatment Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 B Streptococcus (GBS) Infection Treatment Market Drivers
11.2 B Streptococcus (GBS) Infection Treatment Market Restraints
11.3 B Streptococcus (GBS) Infection Treatment Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 B Streptococcus (GBS) Infection Treatment Industry Chain
12.2 B Streptococcus (GBS) Infection Treatment Upstream Analysis
12.3 B Streptococcus (GBS) Infection Treatment Midstream Analysis
12.4 B Streptococcus (GBS) Infection Treatment Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global B Streptococcus (GBS) Infection Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global B Streptococcus (GBS) Infection Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global B Streptococcus (GBS) Infection Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global B Streptococcus (GBS) Infection Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Pfizer Inc. Company Information, Head Office, and Major Competitors
Table 6. Pfizer Inc. Major Business
Table 7. Pfizer Inc. B Streptococcus (GBS) Infection Treatment Product and Solutions
Table 8. Pfizer Inc. B Streptococcus (GBS) Infection Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Pfizer Inc. Recent Developments and Future Plans
Table 10. Alopexx Pharmaceuticals, LLC Company Information, Head Office, and Major Competitors
Table 11. Alopexx Pharmaceuticals, LLC Major Business
Table 12. Alopexx Pharmaceuticals, LLC B Streptococcus (GBS) Infection Treatment Product and Solutions
Table 13. Alopexx Pharmaceuticals, LLC B Streptococcus (GBS) Infection Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Alopexx Pharmaceuticals, LLC Recent Developments and Future Plans
Table 15. Wellstat Vaccines LLC Company Information, Head Office, and Major Competitors
Table 16. Wellstat Vaccines LLC Major Business
Table 17. Wellstat Vaccines LLC B Streptococcus (GBS) Infection Treatment Product and Solutions
Table 18. Wellstat Vaccines LLC B Streptococcus (GBS) Infection Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Wellstat Vaccines LLC Recent Developments and Future Plans
Table 20. Minervax ApS Company Information, Head Office, and Major Competitors
Table 21. Minervax ApS Major Business
Table 22. Minervax ApS B Streptococcus (GBS) Infection Treatment Product and Solutions
Table 23. Minervax ApS B Streptococcus (GBS) Infection Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Minervax ApS Recent Developments and Future Plans
Table 25. Novartis Company Information, Head Office, and Major Competitors
Table 26. Novartis Major Business
Table 27. Novartis B Streptococcus (GBS) Infection Treatment Product and Solutions
Table 28. Novartis B Streptococcus (GBS) Infection Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Novartis Recent Developments and Future Plans
Table 30. GlaxoSmithKline Company Information, Head Office, and Major Competitors
Table 31. GlaxoSmithKline Major Business
Table 32. GlaxoSmithKline B Streptococcus (GBS) Infection Treatment Product and Solutions
Table 33. GlaxoSmithKline B Streptococcus (GBS) Infection Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. GlaxoSmithKline Recent Developments and Future Plans
Table 35. Global B Streptococcus (GBS) Infection Treatment Revenue (USD Million) by Players (2018-2023)
Table 36. Global B Streptococcus (GBS) Infection Treatment Revenue Share by Players (2018-2023)
Table 37. Breakdown of B Streptococcus (GBS) Infection Treatment by Company Type (Tier 1, Tier 2, and Tier 3)
Table 38. Market Position of Players in B Streptococcus (GBS) Infection Treatment, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 39. Head Office of Key B Streptococcus (GBS) Infection Treatment Players
Table 40. B Streptococcus (GBS) Infection Treatment Market: Company Product Type Footprint
Table 41. B Streptococcus (GBS) Infection Treatment Market: Company Product Application Footprint
Table 42. B Streptococcus (GBS) Infection Treatment New Market Entrants and Barriers to Market Entry
Table 43. B Streptococcus (GBS) Infection Treatment Mergers, Acquisition, Agreements, and Collaborations
Table 44. Global B Streptococcus (GBS) Infection Treatment Consumption Value (USD Million) by Type (2018-2023)
Table 45. Global B Streptococcus (GBS) Infection Treatment Consumption Value Share by Type (2018-2023)
Table 46. Global B Streptococcus (GBS) Infection Treatment Consumption Value Forecast by Type (2024-2029)
Table 47. Global B Streptococcus (GBS) Infection Treatment Consumption Value by Application (2018-2023)
Table 48. Global B Streptococcus (GBS) Infection Treatment Consumption Value Forecast by Application (2024-2029)
Table 49. North America B Streptococcus (GBS) Infection Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 50. North America B Streptococcus (GBS) Infection Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 51. North America B Streptococcus (GBS) Infection Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 52. North America B Streptococcus (GBS) Infection Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 53. North America B Streptococcus (GBS) Infection Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 54. North America B Streptococcus (GBS) Infection Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 55. Europe B Streptococcus (GBS) Infection Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 56. Europe B Streptococcus (GBS) Infection Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 57. Europe B Streptococcus (GBS) Infection Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 58. Europe B Streptococcus (GBS) Infection Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 59. Europe B Streptococcus (GBS) Infection Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 60. Europe B Streptococcus (GBS) Infection Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 61. Asia-Pacific B Streptococcus (GBS) Infection Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 62. Asia-Pacific B Streptococcus (GBS) Infection Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 63. Asia-Pacific B Streptococcus (GBS) Infection Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 64. Asia-Pacific B Streptococcus (GBS) Infection Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 65. Asia-Pacific B Streptococcus (GBS) Infection Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 66. Asia-Pacific B Streptococcus (GBS) Infection Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 67. South America B Streptococcus (GBS) Infection Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 68. South America B Streptococcus (GBS) Infection Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 69. South America B Streptococcus (GBS) Infection Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 70. South America B Streptococcus (GBS) Infection Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 71. South America B Streptococcus (GBS) Infection Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 72. South America B Streptococcus (GBS) Infection Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 73. Middle East & Africa B Streptococcus (GBS) Infection Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 74. Middle East & Africa B Streptococcus (GBS) Infection Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 75. Middle East & Africa B Streptococcus (GBS) Infection Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 76. Middle East & Africa B Streptococcus (GBS) Infection Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 77. Middle East & Africa B Streptococcus (GBS) Infection Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 78. Middle East & Africa B Streptococcus (GBS) Infection Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 79. B Streptococcus (GBS) Infection Treatment Raw Material
Table 80. Key Suppliers of B Streptococcus (GBS) Infection Treatment Raw Materials
Table 1. Global B Streptococcus (GBS) Infection Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global B Streptococcus (GBS) Infection Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global B Streptococcus (GBS) Infection Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global B Streptococcus (GBS) Infection Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Pfizer Inc. Company Information, Head Office, and Major Competitors
Table 6. Pfizer Inc. Major Business
Table 7. Pfizer Inc. B Streptococcus (GBS) Infection Treatment Product and Solutions
Table 8. Pfizer Inc. B Streptococcus (GBS) Infection Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Pfizer Inc. Recent Developments and Future Plans
Table 10. Alopexx Pharmaceuticals, LLC Company Information, Head Office, and Major Competitors
Table 11. Alopexx Pharmaceuticals, LLC Major Business
Table 12. Alopexx Pharmaceuticals, LLC B Streptococcus (GBS) Infection Treatment Product and Solutions
Table 13. Alopexx Pharmaceuticals, LLC B Streptococcus (GBS) Infection Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Alopexx Pharmaceuticals, LLC Recent Developments and Future Plans
Table 15. Wellstat Vaccines LLC Company Information, Head Office, and Major Competitors
Table 16. Wellstat Vaccines LLC Major Business
Table 17. Wellstat Vaccines LLC B Streptococcus (GBS) Infection Treatment Product and Solutions
Table 18. Wellstat Vaccines LLC B Streptococcus (GBS) Infection Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Wellstat Vaccines LLC Recent Developments and Future Plans
Table 20. Minervax ApS Company Information, Head Office, and Major Competitors
Table 21. Minervax ApS Major Business
Table 22. Minervax ApS B Streptococcus (GBS) Infection Treatment Product and Solutions
Table 23. Minervax ApS B Streptococcus (GBS) Infection Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Minervax ApS Recent Developments and Future Plans
Table 25. Novartis Company Information, Head Office, and Major Competitors
Table 26. Novartis Major Business
Table 27. Novartis B Streptococcus (GBS) Infection Treatment Product and Solutions
Table 28. Novartis B Streptococcus (GBS) Infection Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Novartis Recent Developments and Future Plans
Table 30. GlaxoSmithKline Company Information, Head Office, and Major Competitors
Table 31. GlaxoSmithKline Major Business
Table 32. GlaxoSmithKline B Streptococcus (GBS) Infection Treatment Product and Solutions
Table 33. GlaxoSmithKline B Streptococcus (GBS) Infection Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. GlaxoSmithKline Recent Developments and Future Plans
Table 35. Global B Streptococcus (GBS) Infection Treatment Revenue (USD Million) by Players (2018-2023)
Table 36. Global B Streptococcus (GBS) Infection Treatment Revenue Share by Players (2018-2023)
Table 37. Breakdown of B Streptococcus (GBS) Infection Treatment by Company Type (Tier 1, Tier 2, and Tier 3)
Table 38. Market Position of Players in B Streptococcus (GBS) Infection Treatment, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 39. Head Office of Key B Streptococcus (GBS) Infection Treatment Players
Table 40. B Streptococcus (GBS) Infection Treatment Market: Company Product Type Footprint
Table 41. B Streptococcus (GBS) Infection Treatment Market: Company Product Application Footprint
Table 42. B Streptococcus (GBS) Infection Treatment New Market Entrants and Barriers to Market Entry
Table 43. B Streptococcus (GBS) Infection Treatment Mergers, Acquisition, Agreements, and Collaborations
Table 44. Global B Streptococcus (GBS) Infection Treatment Consumption Value (USD Million) by Type (2018-2023)
Table 45. Global B Streptococcus (GBS) Infection Treatment Consumption Value Share by Type (2018-2023)
Table 46. Global B Streptococcus (GBS) Infection Treatment Consumption Value Forecast by Type (2024-2029)
Table 47. Global B Streptococcus (GBS) Infection Treatment Consumption Value by Application (2018-2023)
Table 48. Global B Streptococcus (GBS) Infection Treatment Consumption Value Forecast by Application (2024-2029)
Table 49. North America B Streptococcus (GBS) Infection Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 50. North America B Streptococcus (GBS) Infection Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 51. North America B Streptococcus (GBS) Infection Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 52. North America B Streptococcus (GBS) Infection Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 53. North America B Streptococcus (GBS) Infection Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 54. North America B Streptococcus (GBS) Infection Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 55. Europe B Streptococcus (GBS) Infection Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 56. Europe B Streptococcus (GBS) Infection Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 57. Europe B Streptococcus (GBS) Infection Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 58. Europe B Streptococcus (GBS) Infection Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 59. Europe B Streptococcus (GBS) Infection Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 60. Europe B Streptococcus (GBS) Infection Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 61. Asia-Pacific B Streptococcus (GBS) Infection Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 62. Asia-Pacific B Streptococcus (GBS) Infection Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 63. Asia-Pacific B Streptococcus (GBS) Infection Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 64. Asia-Pacific B Streptococcus (GBS) Infection Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 65. Asia-Pacific B Streptococcus (GBS) Infection Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 66. Asia-Pacific B Streptococcus (GBS) Infection Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 67. South America B Streptococcus (GBS) Infection Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 68. South America B Streptococcus (GBS) Infection Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 69. South America B Streptococcus (GBS) Infection Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 70. South America B Streptococcus (GBS) Infection Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 71. South America B Streptococcus (GBS) Infection Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 72. South America B Streptococcus (GBS) Infection Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 73. Middle East & Africa B Streptococcus (GBS) Infection Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 74. Middle East & Africa B Streptococcus (GBS) Infection Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 75. Middle East & Africa B Streptococcus (GBS) Infection Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 76. Middle East & Africa B Streptococcus (GBS) Infection Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 77. Middle East & Africa B Streptococcus (GBS) Infection Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 78. Middle East & Africa B Streptococcus (GBS) Infection Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 79. B Streptococcus (GBS) Infection Treatment Raw Material
Table 80. Key Suppliers of B Streptococcus (GBS) Infection Treatment Raw Materials
LIST OF FIGURES
Figure 1. B Streptococcus (GBS) Infection Treatment Picture
Figure 2. Global B Streptococcus (GBS) Infection Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global B Streptococcus (GBS) Infection Treatment Consumption Value Market Share by Type in 2022
Figure 4. Prenatal-onset GBS Disease
Figure 5. Early-onset GBS Disease
Figure 6. Late-onset GBS Disease
Figure 7. Global B Streptococcus (GBS) Infection Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. B Streptococcus (GBS) Infection Treatment Consumption Value Market Share by Application in 2022
Figure 9. Hospitals Pharmacies Picture
Figure 10. Retail Pharmacies Picture
Figure 11. Online Pharmacies Picture
Figure 12. Global B Streptococcus (GBS) Infection Treatment Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global B Streptococcus (GBS) Infection Treatment Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Market B Streptococcus (GBS) Infection Treatment Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 15. Global B Streptococcus (GBS) Infection Treatment Consumption Value Market Share by Region (2018-2029)
Figure 16. Global B Streptococcus (GBS) Infection Treatment Consumption Value Market Share by Region in 2022
Figure 17. North America B Streptococcus (GBS) Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 18. Europe B Streptococcus (GBS) Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 19. Asia-Pacific B Streptococcus (GBS) Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 20. South America B Streptococcus (GBS) Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 21. Middle East and Africa B Streptococcus (GBS) Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 22. Global B Streptococcus (GBS) Infection Treatment Revenue Share by Players in 2022
Figure 23. B Streptococcus (GBS) Infection Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 24. Global Top 3 Players B Streptococcus (GBS) Infection Treatment Market Share in 2022
Figure 25. Global Top 6 Players B Streptococcus (GBS) Infection Treatment Market Share in 2022
Figure 26. Global B Streptococcus (GBS) Infection Treatment Consumption Value Share by Type (2018-2023)
Figure 27. Global B Streptococcus (GBS) Infection Treatment Market Share Forecast by Type (2024-2029)
Figure 28. Global B Streptococcus (GBS) Infection Treatment Consumption Value Share by Application (2018-2023)
Figure 29. Global B Streptococcus (GBS) Infection Treatment Market Share Forecast by Application (2024-2029)
Figure 30. North America B Streptococcus (GBS) Infection Treatment Consumption Value Market Share by Type (2018-2029)
Figure 31. North America B Streptococcus (GBS) Infection Treatment Consumption Value Market Share by Application (2018-2029)
Figure 32. North America B Streptococcus (GBS) Infection Treatment Consumption Value Market Share by Country (2018-2029)
Figure 33. United States B Streptococcus (GBS) Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 34. Canada B Streptococcus (GBS) Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 35. Mexico B Streptococcus (GBS) Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 36. Europe B Streptococcus (GBS) Infection Treatment Consumption Value Market Share by Type (2018-2029)
Figure 37. Europe B Streptococcus (GBS) Infection Treatment Consumption Value Market Share by Application (2018-2029)
Figure 38. Europe B Streptococcus (GBS) Infection Treatment Consumption Value Market Share by Country (2018-2029)
Figure 39. Germany B Streptococcus (GBS) Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 40. France B Streptococcus (GBS) Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 41. United Kingdom B Streptococcus (GBS) Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 42. Russia B Streptococcus (GBS) Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 43. Italy B Streptococcus (GBS) Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 44. Asia-Pacific B Streptococcus (GBS) Infection Treatment Consumption Value Market Share by Type (2018-2029)
Figure 45. Asia-Pacific B Streptococcus (GBS) Infection Treatment Consumption Value Market Share by Application (2018-2029)
Figure 46. Asia-Pacific B Streptococcus (GBS) Infection Treatment Consumption Value Market Share by Region (2018-2029)
Figure 47. China B Streptococcus (GBS) Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 48. Japan B Streptococcus (GBS) Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 49. South Korea B Streptococcus (GBS) Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 50. India B Streptococcus (GBS) Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 51. Southeast Asia B Streptococcus (GBS) Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 52. Australia B Streptococcus (GBS) Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 53. South America B Streptococcus (GBS) Infection Treatment Consumption Value Market Share by Type (2018-2029)
Figure 54. South America B Streptococcus (GBS) Infection Treatment Consumption Value Market Share by Application (2018-2029)
Figure 55. South America B Streptococcus (GBS) Infection Treatment Consumption Value Market Share by Country (2018-2029)
Figure 56. Brazil B Streptococcus (GBS) Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 57. Argentina B Streptococcus (GBS) Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 58. Middle East and Africa B Streptococcus (GBS) Infection Treatment Consumption Value Market Share by Type (2018-2029)
Figure 59. Middle East and Africa B Streptococcus (GBS) Infection Treatment Consumption Value Market Share by Application (2018-2029)
Figure 60. Middle East and Africa B Streptococcus (GBS) Infection Treatment Consumption Value Market Share by Country (2018-2029)
Figure 61. Turkey B Streptococcus (GBS) Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 62. Saudi Arabia B Streptococcus (GBS) Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 63. UAE B Streptococcus (GBS) Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 64. B Streptococcus (GBS) Infection Treatment Market Drivers
Figure 65. B Streptococcus (GBS) Infection Treatment Market Restraints
Figure 66. B Streptococcus (GBS) Infection Treatment Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of B Streptococcus (GBS) Infection Treatment in 2022
Figure 69. Manufacturing Process Analysis of B Streptococcus (GBS) Infection Treatment
Figure 70. B Streptococcus (GBS) Infection Treatment Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
Figure 1. B Streptococcus (GBS) Infection Treatment Picture
Figure 2. Global B Streptococcus (GBS) Infection Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global B Streptococcus (GBS) Infection Treatment Consumption Value Market Share by Type in 2022
Figure 4. Prenatal-onset GBS Disease
Figure 5. Early-onset GBS Disease
Figure 6. Late-onset GBS Disease
Figure 7. Global B Streptococcus (GBS) Infection Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. B Streptococcus (GBS) Infection Treatment Consumption Value Market Share by Application in 2022
Figure 9. Hospitals Pharmacies Picture
Figure 10. Retail Pharmacies Picture
Figure 11. Online Pharmacies Picture
Figure 12. Global B Streptococcus (GBS) Infection Treatment Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global B Streptococcus (GBS) Infection Treatment Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Market B Streptococcus (GBS) Infection Treatment Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 15. Global B Streptococcus (GBS) Infection Treatment Consumption Value Market Share by Region (2018-2029)
Figure 16. Global B Streptococcus (GBS) Infection Treatment Consumption Value Market Share by Region in 2022
Figure 17. North America B Streptococcus (GBS) Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 18. Europe B Streptococcus (GBS) Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 19. Asia-Pacific B Streptococcus (GBS) Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 20. South America B Streptococcus (GBS) Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 21. Middle East and Africa B Streptococcus (GBS) Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 22. Global B Streptococcus (GBS) Infection Treatment Revenue Share by Players in 2022
Figure 23. B Streptococcus (GBS) Infection Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 24. Global Top 3 Players B Streptococcus (GBS) Infection Treatment Market Share in 2022
Figure 25. Global Top 6 Players B Streptococcus (GBS) Infection Treatment Market Share in 2022
Figure 26. Global B Streptococcus (GBS) Infection Treatment Consumption Value Share by Type (2018-2023)
Figure 27. Global B Streptococcus (GBS) Infection Treatment Market Share Forecast by Type (2024-2029)
Figure 28. Global B Streptococcus (GBS) Infection Treatment Consumption Value Share by Application (2018-2023)
Figure 29. Global B Streptococcus (GBS) Infection Treatment Market Share Forecast by Application (2024-2029)
Figure 30. North America B Streptococcus (GBS) Infection Treatment Consumption Value Market Share by Type (2018-2029)
Figure 31. North America B Streptococcus (GBS) Infection Treatment Consumption Value Market Share by Application (2018-2029)
Figure 32. North America B Streptococcus (GBS) Infection Treatment Consumption Value Market Share by Country (2018-2029)
Figure 33. United States B Streptococcus (GBS) Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 34. Canada B Streptococcus (GBS) Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 35. Mexico B Streptococcus (GBS) Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 36. Europe B Streptococcus (GBS) Infection Treatment Consumption Value Market Share by Type (2018-2029)
Figure 37. Europe B Streptococcus (GBS) Infection Treatment Consumption Value Market Share by Application (2018-2029)
Figure 38. Europe B Streptococcus (GBS) Infection Treatment Consumption Value Market Share by Country (2018-2029)
Figure 39. Germany B Streptococcus (GBS) Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 40. France B Streptococcus (GBS) Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 41. United Kingdom B Streptococcus (GBS) Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 42. Russia B Streptococcus (GBS) Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 43. Italy B Streptococcus (GBS) Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 44. Asia-Pacific B Streptococcus (GBS) Infection Treatment Consumption Value Market Share by Type (2018-2029)
Figure 45. Asia-Pacific B Streptococcus (GBS) Infection Treatment Consumption Value Market Share by Application (2018-2029)
Figure 46. Asia-Pacific B Streptococcus (GBS) Infection Treatment Consumption Value Market Share by Region (2018-2029)
Figure 47. China B Streptococcus (GBS) Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 48. Japan B Streptococcus (GBS) Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 49. South Korea B Streptococcus (GBS) Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 50. India B Streptococcus (GBS) Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 51. Southeast Asia B Streptococcus (GBS) Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 52. Australia B Streptococcus (GBS) Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 53. South America B Streptococcus (GBS) Infection Treatment Consumption Value Market Share by Type (2018-2029)
Figure 54. South America B Streptococcus (GBS) Infection Treatment Consumption Value Market Share by Application (2018-2029)
Figure 55. South America B Streptococcus (GBS) Infection Treatment Consumption Value Market Share by Country (2018-2029)
Figure 56. Brazil B Streptococcus (GBS) Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 57. Argentina B Streptococcus (GBS) Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 58. Middle East and Africa B Streptococcus (GBS) Infection Treatment Consumption Value Market Share by Type (2018-2029)
Figure 59. Middle East and Africa B Streptococcus (GBS) Infection Treatment Consumption Value Market Share by Application (2018-2029)
Figure 60. Middle East and Africa B Streptococcus (GBS) Infection Treatment Consumption Value Market Share by Country (2018-2029)
Figure 61. Turkey B Streptococcus (GBS) Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 62. Saudi Arabia B Streptococcus (GBS) Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 63. UAE B Streptococcus (GBS) Infection Treatment Consumption Value (2018-2029) & (USD Million)
Figure 64. B Streptococcus (GBS) Infection Treatment Market Drivers
Figure 65. B Streptococcus (GBS) Infection Treatment Market Restraints
Figure 66. B Streptococcus (GBS) Infection Treatment Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of B Streptococcus (GBS) Infection Treatment in 2022
Figure 69. Manufacturing Process Analysis of B Streptococcus (GBS) Infection Treatment
Figure 70. B Streptococcus (GBS) Infection Treatment Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
